Changing profiles of injecting drug users with AIDS in a Hispanic population

Addiction

Volumn 99, Issue 9, 2004, Pages 1147-1156

  Amill, Alejandro ^a   Gómez, María De Los A ^a   Fernández, Diana M ^a   Bangdiwala, Shrikant I ^b   Ríos, Eddy ^c   Hunter, Robert F ^a  

^a SCHOOL OF MEDICINE   (Puerto Rico)

^b The University of North Carolina at Chapel Hill   (United States)

^c Universidad Central de Caribe   (Puerto Rico)

Author keywords

AIDS; Intravenous drug (ID) use; Puerto Rico; Trends

Indexed keywords

AMPHETAMINE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COCAINE; DIAMORPHINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL PNEUMONIA; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; HEPATITIS C; HISPANIC; HUMAN; IMMUNOLOGICAL PARAMETERS; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; PUERTO RICO; SOCIOECONOMICS; THRUSH; TOXOPLASMOSIS; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; CD4 LYMPHOCYTE COUNT; COCAINE-RELATED DISORDERS; COHORT STUDIES; EDUCATIONAL STATUS; HEROIN DEPENDENCE; HUMANS; MALE; NEEDLE SHARING; PNEUMONIA, BACTERIAL; PREVALENCE; PUERTO RICO; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; WASTING SYNDROME;

EID: 4544279770     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00812.x     Document Type: Article

References (51)

1. Alder, W., Baskar, P., Chrest, F., Dorsey-Cooper, B., Winchurch, R. & Nagel. J. (1997) HIV infection and aging: mechanism to explain the accelerated rate of progression in the older patient. Mechanisms of Ageing and Development, 96. 137-155.
2. van Beek, I., Dwyer, R., Dore, G., Lou, K. & Kaldor, J. (1998) Infection with hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ, 371, 433-447.
3. Bureau of HIV/AIDS. STD & TB Update Series (2001) HIV/AIDS Epi Update. Ottawa, Ontario: Centers for Infectious Disease Prevention and Control.
4. Center for Disease Control and Prevention (1992) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, Morbidity and Mortality Monthly Report, 41, 1-19.
5. Center for Disease Control and Prevention (1998) Recommendations for preventing and control of (HCV) infection and HCV-related chronic diseases. Morbidity and Mortality Monthly Report, 47, 1-39.
6. Center for Disease Control and Prevention (2000b) HTV/AIDS among men who have sex with men and inject drugs-United States, 1985-98. Morbidity and Mortality Monthly Report, 49, 465-470.
7. Center for Disease Control and Prevention (CDC) (2001) HIV Surveillance Report. Midyear Edition, p. 13. Atlanta, GA: CDC.
8. Center for Disease Control and Prevention (CDC) and World Health Organization (WHO) (1997) Epi Info. Version 6.04. Atlanta, GA. USA: CDC/Geneva. Switzerland: WHO.
9. Centers for Disease Control and Prevention (2000a) HIV/AIDS Surveillance. General Epidemiology L178 slides series, Slide 9 of 23. Atlanta. GA: CDC.
10. Central Program for AIDS and Sexually Transmitted Diseases (2002) Puerto Rico AIDS Surveillance Report. San Juan, Puerto Rico: Commonwealth of Puerto Rico Health Department.
11. Colón, H., Finlinson, H., Robles, R., Deren, S., Andía, J., Kang, S. & Oliver-Valez, D. (2001) Joint drug purchase and drug preparation risk behaviors among Puerto Rican injection drug users. AIDS and Behavior, 5, 85-96.
12. Coodley, G., Loveless, M. & Merrill, T. (1994) The HIV wasting syndrome: a review. Journal of Acquired Immune Deficiency Syndromes, 7, 681-694.
13. Deren, S., Robles, R., Andia, J., Colón, H., Kang, S. & Perils, T. (2001) Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999. Journal of Acquired Immune Deficiency Syndromes, 26, 164-169.
14. Des Jarlais, D., Friedman, S., Perils, T., Chapman, T., Sotheran, J., Paone, D., Monterroso, E. & Neaigus, A. (1999) Risk behavior and HIV infection among new injectors in the era of AIDS in New York. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 67-72.
15. Des Jarlais, D., Friedman, S. & Ward, T. (1994) HIV and injecting drug users: special considerations. In: Broder, S., Merigan, T., Bolognesi, D., eds. Textbook of AIDS Medicine, pp. 183-191. Baltimore. MD: Williams & Wilkins.
16. Des Jarlais, D., Marmor, M., Friedman, P. & Titus, S. (2000a) HIV incidence among Injection drug users in New York, 1990-1997: evidence for a declining epidemic. American Journal of Public Health, 90, 352-359.
17. Des Jarlais, D., Perils, T., Friedman, S. & Chapman, T. (2000b) Behavior risk reduction in a declining HIV epidemic: injection drug users in New York City. 1990-1997. American Journal of Public Health, 90, 1112-1116.
18. Dodig, M. & Tavill, A. (2001) Hepatitis C and human immunodeficiency virus co-infection. Journal of Clinical Gastroenterology, 33, 367-374.
19. Easterbrook, P., Me Yu. L., Goetgheberur, E., Boag, F., McLean, K. & Gazzard, B. (2000) Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS, 14, 561-571.
20. Farizo, K. M., Buehler, J., Chamberland, M., Wythe, B., Froelicher, E., Hopkins, S., Reed, C., Mokotoff, E., Cohn, D., Troxle, S., Phelps, A. & Berkelman, R. (1992) Spectrum of disease in persons with human immunodeficiency virus infection in the United Sates. Journal of the American Medical Association, 267, 1798-1805.
21. Fernández, D., Gómez, M., Mayor, A., Gómez, O. & Hunter, R. (2001) Survival of AIDS according to injecting drug use among Puerto Rican AIDS patients. Cellular and Molecular Biology, 47, 1121-1127.
22. Friedman, S., Curtis, R., Neaigus, A., Jose, B. & Des Jarlais, D. (1999) Syringe sharing and the social characteristics of drug-injecting dyads. In: Social Networks. Drug Injectors' Lives and HIV/AIDS, pp. 143-154. New York, NY: Kluwer Academic/Plenum Publishers.
23. Gallagher, T., Anderson, R., Koegel, P. & Gelberg, L. (1997) Determinants of regular source of care among homeless adults in Los Angeles. Medical Care, 35, 814-830.
24. Gómez, M., Fernández, D. & Hunter, R. (1997a) Psycho social and clinical spectrum of HIV/AIDS injecting drug users in Bayamón. Puerto Rico. Cellular and Molecular Biology, 43, 1145-1152.
25. Gómez, M., Fernández, D., Otero, J., Miranda, S. & Hunter, R. (2001) The shape of the HIV/AIDS, epidemic in Puerto Rico. Panamerican Journal of Public Health, 7, 377-382.
26. Gómez, M., Velásquez, M. & Hunter, R. (1997b) Outline of the human retrovirus registry: profile of a Puerto Rican HIV infected population. Boletín Asociación Médica de Puerto Rico [Bulletin of the Medical Association of Puerto Rico]. 89, 111-116.
27. Hagan, H., McGough, J., Thiede, H., Hopkins, S., Duchin, J. & Alexander, E. (2000) Reduce injection frequency and increase entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse and Treatment, 19, 247-252.
28. Hirschtick, R., Glassroth, J., Jordan, M., Wilcosky, T., Wallace, J., Kvale, P., Markowitz, N., Rosen, M., Mangura, B. & Hopewell, P. (1995) Bacterial pneumonia in persons infected with the human immunodeficiency virus. New England Journal of Medicine, 333, 845-851.
29. Hutchinson, S., Taylor, A., Goldberg, D. & Gruer, L. (2000) Factors associated with injecting behavior among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne virus. Addiction, 95, 931-940.
30. Jones, J., Hanson, D., Dworkin, M., Kaplan, J. & Ward, J. (1998) Trends in AIDS-related opportunistic infections among men who have sex with men and injecting drugs users, 1991-1996. Journal of Infectious Diseases, 178, 114-120.
31. Karon, J., Fleming, P., Steketee, R. & De Cock, K. (2001) HIV in the United States at the turn of the century: an epidemic in transition. American Journal of Public Health, 91, 1060-1068.
32. Krol, A., Flynn, C., Valhov, D., Miedema, F., Coutinho, R. A. & van Ameijden, E. (1999) New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users. Drug and Alcohol Dependence, 54, 145-154.
33. Laine, C., Hauck, W., Gourevitch, M., Rothman, J., Cohen, A. & Turner, B. (2001) Regular outpatient medical and drug abuse care and subsequent hospitalisation of persons who use illicit drugs. Journal of the American Medical Association, 285, 2355-2362.
34. Lyles, C., Margolick, J., Astemborski, J., Graham, N., Anthony, J., Hoover, D. & Vlahov, D. (1997) The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users. AIDS, 11, 1255-1262.
35. Mesquita, F., Kral, A., Reingold, A. & Bueno, R. (2001) Trends of HIV infection among injection drug users in Brazil in the 1990s: the impact of changes in patterns of drug use. Journal of Acquired Immune Deficiency Syndromes, 28, 298-302.
36. Murill, C., Weeks, H., Castrucci, B., Weinstock, H., Bell, B., Spurill, C. & Gwinn, M. (2002) Age-specific seroprevalence of HIV, hepatitis B Virus, hepatitis C virus infection among injecting drug users admitted to drug treatment in 6 US cities. American Journal of Public Health, 92, 385-387.
37. Nahlen, B., Chu, S., Nwanyanwu, O., Berklman, R., Martinez, S. & Rullan, J. (1993) HIV wasting syndrome in the United States. AIDS, 7, 183-188.
38. O'Connor, P., Selwyn, P. & Schottenfeld, R. (1994) Medical care for injection-drug users with human immunodeficiency virus infection. New England Journal of Medicine, 331, 450-459.
39. Patrick, D., Tyndall, M., Cornelisse, P., Li, K., Sherlock, C., Rekart, M., Strathdee, S., Currie, S., Schechter, M. & O'Shaughnessy, M. (2001) Incidence of hepatitis C infection among injection drug users during an outbreak if HIV infection, Canadian Medical Association Journal, 165, 889-895.
40. Pett, M. (1997) Nonpammetric Statistics for Health Care Research, 1st edn. Thousand Oaks, CA: SAGE.
41. Prevots, R., Allen, D., Lehman, S., Green, T., Petersen, L. & Gwinn, M. (1996) Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993. American Journal of Epidemiology, 143, 733-742.
42. Saag, M. (1994) Natural history of HIV-1 disease. In: Broder, S., Merigan, T., Bolognesi, D., eds. Textbook of AIDS Medicine, pp. 45-54. Baltimore, MD: Williams & Wilkins.
43. SAS Institute (2000) SAS System Release 8, 1 for Windows, Cary, NC; SAS Institute, Inc.
44. Schoenbaum, E., Hartel, D. & Gourevitch, M. (1996) Needle exchange use among a cohort of injecting drug users, AIDS, 10, 1729-1734.
45. Selik, R., Chu, S. & Ward, M. (1995) Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Annals of Internal Medicine, 123, 933-936.
46. Serfaty, L., Costagliola, D., Wendum, D., Picar, O., Meyohas, M., Giirard, P., Lebas, J., Delamare, C. & Poupon, Housset, C. (2001) Impact of early-untreated HIV infection on hepatitis C in intravenous drug users: a case-control study. AIDS. 15, 2011-2016.
47. Song, J., Safenian, M., Strathdee, S., Vlahov, D. & Celentano, D. (2000) The prevalence of homeless injecting drug users with and without Infection. Journal of Urban Health, 77, 678-687.
48. SPSS Inc. (2001) SPSS 11.0 System for Windows. Chicago, IL: SPSS, Inc.
49. Stein, D., Korvick, J. & Vermund, S. (1992) CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease; a review. Journal of Infectious Diseases, 166, 352-363.
50. Strathdee, S. A., Palepu, A. & Cornelisse, P. G. (1998) Barriers to use of free antiretroviral therapy in injecting drug users. Journal of the American Medical Association, 280, 547-549.
51. UNAIDS (Joint United Nation Programme on HTV/AIDS) and WHO (World Health Organization) (2001) AIDS Epidemic Update, Geneva, UNAIDS/WHO.